{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:43:46Z","timestamp":1789501426205,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T00:00:00Z","timestamp":1487721600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00223-017-0241-z","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T06:34:57Z","timestamp":1487745297000},"page":"595-598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series"],"prefix":"10.1007","volume":"100","author":[{"given":"Giovanni","family":"Orsolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Gavioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Tripi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ombretta","family":"Viapiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Idolazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Zanotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,22]]},"reference":[{"key":"241_CR1","first-page":"13","volume":"315","author":"G Krishnaswamy","year":"2006","unstructured":"Krishnaswamy G, Ajitawi O, Chi DS (2006) The human mast cell: an overview. Methods Mol Biol 315:13\u201334","journal-title":"Methods Mol Biol"},{"key":"241_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1586\/ehm.10.42","volume":"3","author":"M Arock","year":"2010","unstructured":"Arock M, Valent P (2010) Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives. Expert Rev Hematol 3:497\u2013516","journal-title":"Expert Rev Hematol"},{"key":"241_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1586\/ehm.12.12","volume":"5","author":"WR Sperr","year":"2012","unstructured":"Sperr WR, Valent P (2012) Diagnosis, progression patterns and prognostication in mastocytosis. Expert Rev Hematol 5:261\u2013274","journal-title":"Expert Rev Hematol"},{"key":"241_CR4","first-page":"159","volume":"3","author":"P Valent","year":"2013","unstructured":"Valent P (2013) Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathology. Am J Cancer Res 3:159\u2013172","journal-title":"Am J Cancer Res"},{"key":"241_CR5","doi-asserted-by":"publisher","first-page":"7005","DOI":"10.3748\/wjg.14.7005","volume":"14","author":"JK Lee","year":"2008","unstructured":"Lee JK, Whittaker SJ, Enns RA, Zetler P (2008) Gastrointestinal manifestations of systemic mastocytosis. World J Gastroenterol 14:7005\u20137008","journal-title":"World J Gastroenterol"},{"key":"241_CR6","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/ajh.24553","volume":"91","author":"A Pardanani","year":"2016","unstructured":"Pardanani A (2016) Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management. Am J Hematol 91:1146\u20131159","journal-title":"Am J Hematol"},{"key":"241_CR7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","volume":"37","author":"P Valent","year":"2007","unstructured":"Valent P, Akin C, Escribano L, Fodinger M, Hartmann K, Brockow K, Castells M, Sperr WR, Kluin-Nelemans HC, Hamdy NA, Lortholary O, Robyn J, van Doormaal J, Sotlar K, Hauswirth AW, Arock M, Hermine O, Hellmann A, Triggiani M, Niedoszytko M, Schwartz LB, Orfao A, Horny HP, Metcalfe DD (2007) Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 37:435\u2013453","journal-title":"Eur J Clin Invest"},{"key":"241_CR8","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.bone.2011.07.004","volume":"49","author":"M Rossini","year":"2011","unstructured":"Rossini M, Zanotti R, Bonadonna P, Artuso A, Caruso B, Schena D, Vecchiato D, Bonifacio M, Viapiana O, Gatti D, Senna G, Riccio A, Passalacqua G, Pizzolo G, Adami S (2011) Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis. Bone 49:880\u2013885","journal-title":"Bone"},{"key":"241_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.iac.2014.01.011","volume":"34","author":"M Rossini","year":"2014","unstructured":"Rossini M, Zanotti R, Viapiana O, Tripi G, Orsolini G, Idolazzi L, Bonadonna P, Schena D, Escribano L, Adami S, Gatti D (2014) Bone involvement and osteoporosis in mastocytosis. Immunol Allergy Clin North Am 34:383\u2013396","journal-title":"Immunol Allergy Clin North Am"},{"key":"241_CR10","doi-asserted-by":"crossref","unstructured":"Artuso A, Caimmi C, Tripi G, Viapiana O, Bonifacio M, Idolazzi L, Gavioli I, Gatti D, Zanotti R, Rossini M (2016) Longitudinal evaluation of bone mineral density and bone metabolism markers in patients with indolent systemic mastocytosis without osteoporosis. Calcif Tissue Int","DOI":"10.1007\/s00223-016-0198-3"},{"key":"241_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jbspin.2012.08.013","volume":"80","author":"L Frenzel","year":"2013","unstructured":"Frenzel L, Hermine O (2013) Mast cells and inflammation. Joint Bone Spine 80:141\u2013145","journal-title":"Joint Bone Spine"},{"issue":"1234\u20131237","key":"241_CR12","first-page":"e1237","volume":"132","author":"A Rabenhorst","year":"2013","unstructured":"Rabenhorst A, Christopeit B, Leja S, Gerbaulet A, Kleiner S, Forster A, Raap U, Wickenhauser C, Hartmann K (2013) Serum levels of bone cytokines are increased in indolent systemic mastocytosis associated with osteopenia or osteoporosis. J Allergy Clin Immunol 132(1234\u20131237):e1237","journal-title":"J Allergy Clin Immunol"},{"issue":"75","key":"241_CR13","first-page":"e71","volume":"126","author":"N Guillaume","year":"2013","unstructured":"Guillaume N, Desoutter J, Chandesris O, Merlusca L, Henry I, Georgin-Lavialle S, Barete S, Hirsch I, Bouredji D, Royer B, Gruson B, Lok C, Sevestre H, Mentaverri R, Brazier M, Meynier J, Hermine O, Marolleau JP, Kamel S, Damaj G (2013) Bone complications of mastocytosis: a link between clinical and biological characteristics. Am J Med 126(75):e71\u2013e77","journal-title":"Am J Med"},{"key":"241_CR14","first-page":"672","volume":"44","author":"AS Ali","year":"2006","unstructured":"Ali AS, Lax AS, Liljestrom M, Paakkari I, Ashammakhi N, Kovanen PT, Konttinen YT (2006) Mast cells in atherosclerosis as a source of the cytokine RANKL. Clin Chem Lab Med 44:672\u2013674","journal-title":"Clin Chem Lab Med"},{"key":"241_CR15","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1007\/s00198-016-3539-1","volume":"27","author":"M Rossini","year":"2016","unstructured":"Rossini M, Zanotti R, Orsolini G, Tripi G, Viapiana O, Idolazzi L, Zamo A, Bonadonna P, Kunnathully V, Adami S, Gatti D (2016) Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis. Osteoporos Int 27:2411\u20132421","journal-title":"Osteoporos Int"},{"issue":"1127","key":"241_CR16","first-page":"e1121","volume":"127","author":"M Rossini","year":"2014","unstructured":"Rossini M, Zanotti R, Viapiana O, Tripi G, Idolazzi L, Biondan M, Orsolini G, Bonadonna P, Adami S, Gatti D (2014) Zoledronic acid in osteoporosis secondary to mastocytosis. Am J Med 127(1127):e1121\u2013e1124","journal-title":"Am J Med"},{"key":"241_CR17","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1007\/s00198-015-3234-7","volume":"26","author":"S Papapoulos","year":"2015","unstructured":"Papapoulos S, Lippuner K, Roux C, Lin CJ, Kendler DL, Lewiecki EM, Brandi ML, Czerwinski E, Franek E, Lakatos P, Mautalen C, Minisola S, Reginster JY, Jensen S, Daizadeh NS, Wang A, Gavin M, Libanati C, Wagman RB, Bone HG (2015) The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study. Osteoporos Int 26:2773\u20132783","journal-title":"Osteoporos Int"},{"key":"241_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1517\/14740338.2016.1136287","volume":"15","author":"M Rossini","year":"2016","unstructured":"Rossini M, Adami G, Adami S, Viapiana O, Gatti D (2016) Safety issues and adverse reactions with osteoporosis management. Expert Opin Drug Saf 15:321\u2013332","journal-title":"Expert Opin Drug Saf"},{"key":"241_CR19","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.1210\/jc.2010-0597","volume":"95","author":"IR Reid","year":"2010","unstructured":"Reid IR, Gamble GD, Mesenbrink P, Lakatos P, Black DM (2010) Characterization of and risk factors for the acute-phase response after zoledronic acid. J Clin Endocrinol Metab 95:4380\u20134387","journal-title":"J Clin Endocrinol Metab"},{"key":"241_CR20","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.bone.2011.08.007","volume":"49","author":"Y Kumagai","year":"2011","unstructured":"Kumagai Y, Hasunuma T, Padhi D (2011) A randomized, double-blind, placebo-controlled, single-dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of denosumab administered subcutaneously to postmenopausal Japanese women. Bone 49:1101\u20131107","journal-title":"Bone"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-017-0241-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-017-0241-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-017-0241-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T19:51:42Z","timestamp":1568836302000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-017-0241-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,22]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["241"],"URL":"https:\/\/doi.org\/10.1007\/s00223-017-0241-z","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,22]]}}}